Fed Policymakers Inflation Worries Weighed On Rate Cut Outlook At Warsh’s First Meeting
Minutes from the FOMC meeting under Warsh reveal inflation worries clouding the outlook for rate cuts.
Latest analysis
More stories
Warsh Reaffirms Fed’s “No Tolerance” For Elevated Inflation In House Hearing
Fed Chair Kevin Warsh told the House Financial Services Committee that the Fed has no tolerance for persistently elevated inflation.
Goldman Sachs and JPMorgan Chase Earn AI-Winner Crown in Record-Q2 Markets Burst
Goldman Sachs and JPMorgan Chase reported record quarterly revenue driven by AI-fueled trading, equity markets activity, and advisory fees, signaling a broader AI-led financing...
Gas Prices Drag US Inflation Lower as Energy Volatility persists
US inflation eased in June as energy and gasoline prices fell, but renewed Middle East tensions kept the outlook uncertain.
June CPI Shows Inflation Cooldown Amid Energy Declines, Fed Watch Remains paramount
The June CPI fell 0.4% month over month, with energy driving the headline decline and core prices showing resilience.
Iran War Costs and Lingering Effects Reshape Global Economy and Markets
The Iran war pushed energy prices higher, strained housing affordability, and disrupted global supply chains, casting a long shadow over markets and policy for...
Oil Prices Fluctuate As Trump Iran Deal Could Reopen Strait Of Hormuz
Oil prices moved between gains and modest declines as markets awaited a framework deal between the U.S.
Fed Holds U.S. Interest Rates Steady as Iran Deal Uncertainty Lingers
The Fed leaves the target range for the federal funds rate at 3.5%-3.75% after Warsh’s first meeting, with inflation around 3.8% and Iran-related uncertainty...
CarMax Q1 Beats Earnings as Barr Unveils Multiyear Turnaround Plan
CarMax beats quarterly expectations as Keith Barr unveils a multiyear plan to turn around the business, underscoring margin pressures and a push toward a...
JetBlue to Trim Newark, LaGuardia Footprint as It Expands in Fort Lauderdale
JetBlue will close its flight attendant base at Newark and tech operations bases at Newark and LaGuardia this fall to cut costs, while expanding...
UniQure Seeks FDA Ok For Huntington’s Disease Gene Therapy After Regulatory Reversal
UniQure announced plans to seek FDA approval for its Huntington’s disease gene therapy, following a recent meeting in which the agency signaled that a...